BOUNDLESS BIO INC (BOLD:NASDAQ)
$2.41 -0.1 (-3.9841%)
Analysed BOUNDLESS BIO INC (BOLD:NASDAQ) News Sources
Boundless Bio to Participate in the Leerink Global Healthcare Conference
04-03-2026
yahoo.com
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
09-03-2026
yahoo.com
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
17-03-2026
yahoo.com
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
17-04-2026
yahoo.com
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
08-05-2026
yahoo.com
Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement
23-06-2026
yahoo.com
BOLD Stock Is Up 90% — Here's What's Behind The Biggest Rally In Company History
23-06-2026
stocktwits.com
Sector Update: Healthcare Stocks Advance in Afternoon Trading
23-06-2026
yahoo.com
Sector Update: Healthcare Stocks Higher Late Afternoon
23-06-2026
yahoo.com
Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today
24-06-2026
stocktwits.com
What is the current price of BOUNDLESS BIO INC (BOLD:NASDAQ)?
The current price of BOUNDLESS BIO INC (BOLD:NASDAQ) is $2.41.
BOUNDLESS BIO INC (BOLD:NASDAQ) absolute price change since previous trading day?
The absolute price change of BOUNDLESS BIO INC (BOLD:NASDAQ) since the previous trading day is $-0.1.
BOUNDLESS BIO INC (BOLD:NASDAQ) percentage price change since previous trading day?
The percentage price change of BOUNDLESS BIO INC (BOLD:NASDAQ) since the previous trading day is -3.9841%.
What is the most recent average sentiment score for BOUNDLESS BIO INC (BOLD:NASDAQ)?
The most recent average sentiment score for BOUNDLESS BIO INC (BOLD:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for BOUNDLESS BIO INC (BOLD:NASDAQ)?
The most recent sentiment for BOUNDLESS BIO INC (BOLD:NASDAQ) is .
SEC-8K** Filing Available For BOUNDLESS BIO INC (BOLD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.